Drug intelligence / Profile preview

standard treatment + xiyanping

Development stage
Unknown
Lead developer
Jiangxi Qingfeng Pharmaceutical
Modality
Drug Delivery Systems, Small Molecules
Administration
Intravenous, Oral, Intramuscular, Rectal
01

Overview

This is a combination therapy consisting of "standard treatment" (which typically refers to the established or guideline-recommended care for a given disease, such as supportive care, antibiotics, antivirals, or other symptomatic treatments) plus Xiyanping injection. Xiyanping is a traditional Chinese medicine injection whose main active ingredient is andrographolide sulfonate. It has demonstrated antimicrobial, antiviral, anti-inflammatory and immune-regulating effects. The combination of standard treatment with Xiyanping has been studied in various infectious diseases including community-acquired pneumonia, bronchopneumonia in children, acute tonsillitis (including suppurative forms), COVID-19 (mild to moderate), and others. Clinical studies suggest that adding Xiyanping to standard regimens can improve symptom resolution times (such as fever and cough), reduce hospital stay duration and may enhance overall clinical efficacy compared to standard therapy alone[5][8][10]. The mechanism of action for Xiyanping centers on inhibition of inflammatory mediators and modulation of immune responses.

Other names
standard therapy + xiyanpingroutine treatment + xiyanpingconventional treatment + xiyanping
02

Targets

MAPK3 (Mitogen-activated protein kinase 1)HSP90AA1 (Heat shock protein HSP90-alpha)

Beyond the preview

Go deeper on standard treatment + xiyanping.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on standard treatment + xiyanping.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call